A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT((R))) Randomized Controlled Trial.

This content is restricted to subscribers. If you are already a subscriber, please log in.